Section Arrow
CLDX.NASDAQ
- Celldex Therapeutics
Quotes are at least 15-min delayed:2025/11/16 06:49 EST
Regular Hours
Last
 25.55
+1.83 (+7.72%)
Day High 
25.62 
Prev. Close
23.72 
1-M High
28.59 
Volume 
962.60K 
Bid
21.5
Ask
26.06
Day Low
23.47 
Open
23.47 
1-M Low
22.1 
Market Cap 
1.58B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 24.02 
20-SMA 25.44 
50-SMA 25.51 
52-W High 29.05 
52-W Low 14.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.01/-4.03
Enterprise Value
1.58B
Balance Sheet
Book Value Per Share
9.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.02M
Operating Revenue Per Share
0.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed:2025/11/16 06:49 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.